XML 53 R39.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2019
Fair Value Disclosures [Abstract]  
Schedule of estimated fair value of derivatives measured by level of fair value hierarchy
The Company’s financial assets and liabilities measured and reported at fair value on a recurring basis include the following as of:
March 31, 2019December 31, 2018
Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Derivative assets(1)
$— $10,463 $— $10,463 $— $16,687 $— $16,687 
Non-real estate investments(1)
$— $3,138 $— $3,138 $— $2,713 $— $2,713 
___________ 
1.Included in the prepaid expenses and other assets, net line item on the Consolidated Balance Sheets.
Schedule of carrying value and fair value of notes payable
The table below represents the carrying value and fair value of the Company’s investment in securities and debt as of:
March 31, 2019December 31, 2018
Carrying Value
Fair Value
Carrying Value
Fair Value
Assets
U.S. Government securities$144,992 $147,913 $146,880 $147,686 
Liabilities
Unsecured debt(1)(2)
$2,364,728 $2,354,445 $2,274,352 $2,227,265 
Secured debt(1)
$365,237 $357,572 $365,381 $354,109 
In-substance defeased debt$137,417 $136,287 $138,223 $135,894 
Joint venture partner debt$66,136 $68,259 $66,136 $66,136 
_________________
1.Amounts represent debt excluding net deferred financing costs.
2.The 3.95% registered senior notes and the 4.65% registered senior notes were issued at a discount. The discount, net of amortization, was $5.3 million and $0.6 million at March 31, 2019 and December 31, 2018, respectively, and is included within unsecured debt.